The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia

The treatment of acute leukemia in childhood has been increasingly successful. Infectious complications are the major cause of morbidity and mortality among these patients receiving aggressive chemotherapy. In particular, neutropenic enterocolitis or typhlitis has had a reported mortality of 50% to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1986-02, Vol.57 (3), p.603-609
Hauptverfasser: Shamberger, Robert C., Weinstein, Howard J., Delorey, Marcia J., Levey, Raphael H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 609
container_issue 3
container_start_page 603
container_title Cancer
container_volume 57
creator Shamberger, Robert C.
Weinstein, Howard J.
Delorey, Marcia J.
Levey, Raphael H.
description The treatment of acute leukemia in childhood has been increasingly successful. Infectious complications are the major cause of morbidity and mortality among these patients receiving aggressive chemotherapy. In particular, neutropenic enterocolitis or typhlitis has had a reported mortality of 50% to 100%. The authors reviewed a series of 77 previously untreated patients with acute myelogenous leukemia begun on treatment from March 1976 to June of 1984 to better define the characteristics of typhlitis and its optimum management. Twenty‐five patients had episodes of typhlitis, characterized by fever, abdominal pain, and tenderness, occurring during periods of neutropenia. Ten of these patients had watery diarrhea as a major additional symptom, and nine patients had a significant episode of gastrointestinal bleeding. In seven instances, blood culture results were positive, all for intestinal flora. The episodes of typhlitis occurred most frequently during the induction therapy (19 patients). Five patients experienced typhlitis during maintenance therapy, and one patient had acute appendicitis. Two patients had typhlitis during their reinduction therapy, and of note, one had had abdominal symptoms during her initial induction. All patients were treated initially with broad‐spectrum antibiotics and bowel rest. Four criteria have been used for surgical intervention: (1) persistent gastrointestinal bleeding after resolution of neutropenia and thrombocytopenia and correction of clotting abnormalities; (2) evidence of free intraperitoneal perforation; (3) clinical deterioration requiring support with vasopressors, or large volumes of fluid, suggesting uncontrolled sepsis; and (4) development of symptoms of an intra‐abdominal process, in the absence of neutropenia, which would normally require surgery. Using these criteria, five patients required surgical intervention for typhlitis or its sequelae and one for acute appendicitis. There was one perioperative death resulting from miliary tuberculosis. Among the 21 patients managed medically, there was 1 death resulting from typhlitis in a patient in whom surgery was deferred because of her multiple failures to enter remission.
doi_str_mv 10.1002/1097-0142(19860201)57:3<603::AID-CNCR2820570335>3.0.CO;2-K
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76685493</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76685493</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4955-4e82ff61597e6b2d356726d623c5924a09eada952ad3c89555d3b4ce563be4c23</originalsourceid><addsrcrecordid>eNqVUVtr1EAYHUSpa-tPEOZBpH3IOplbklWEGm-lxQWpIL4Ms5Mvm7GTyZpJKPn3znbXBftQ8Onj41w4nIPQ-5TMU0Lo65QUWUJSTk_TIpeEkvRMZAv2VhK2WJxffEjKr-U3mlMiMsKYeMfmZF4u39Dk8hGaHcSP0YwQkieCsx9P0bMQfsU3o4IdoSPGcy5FMUPtdQO4hcoa7bD2FQ5jv757Wu31GlrwA-5qPEybxtnBBmw9No11VQ8e39qhwdqMA2DfeTe1m6Yz02ANPm0ncN0afDeGM-xgvIHW6hP0pNYuwPP9PUbfP328Lr8kV8vPF-X5VWJ4IUTCIad1LVNRZCBXtGJCZlRWkjIjCso1KUBXuhBUV8zkUSEqtuIGhGQr4IayY_Rq57vpu98jhEG1NhhwTnuIgVQmZS54wSLx545o-i6EHmq16W2r-0mlRG23UNs61bZO9XcLJTLFVNxCqbiF-neLiBBVLhVVl9H8xT7FuIoVH6z35Uf85R7XITZe99obGw60XOSMSxlpsKPdWgfTfwV8MN89hP0BPKW0kw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76685493</pqid></control><display><type>article</type><title>The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Shamberger, Robert C. ; Weinstein, Howard J. ; Delorey, Marcia J. ; Levey, Raphael H.</creator><creatorcontrib>Shamberger, Robert C. ; Weinstein, Howard J. ; Delorey, Marcia J. ; Levey, Raphael H.</creatorcontrib><description>The treatment of acute leukemia in childhood has been increasingly successful. Infectious complications are the major cause of morbidity and mortality among these patients receiving aggressive chemotherapy. In particular, neutropenic enterocolitis or typhlitis has had a reported mortality of 50% to 100%. The authors reviewed a series of 77 previously untreated patients with acute myelogenous leukemia begun on treatment from March 1976 to June of 1984 to better define the characteristics of typhlitis and its optimum management. Twenty‐five patients had episodes of typhlitis, characterized by fever, abdominal pain, and tenderness, occurring during periods of neutropenia. Ten of these patients had watery diarrhea as a major additional symptom, and nine patients had a significant episode of gastrointestinal bleeding. In seven instances, blood culture results were positive, all for intestinal flora. The episodes of typhlitis occurred most frequently during the induction therapy (19 patients). Five patients experienced typhlitis during maintenance therapy, and one patient had acute appendicitis. Two patients had typhlitis during their reinduction therapy, and of note, one had had abdominal symptoms during her initial induction. All patients were treated initially with broad‐spectrum antibiotics and bowel rest. Four criteria have been used for surgical intervention: (1) persistent gastrointestinal bleeding after resolution of neutropenia and thrombocytopenia and correction of clotting abnormalities; (2) evidence of free intraperitoneal perforation; (3) clinical deterioration requiring support with vasopressors, or large volumes of fluid, suggesting uncontrolled sepsis; and (4) development of symptoms of an intra‐abdominal process, in the absence of neutropenia, which would normally require surgery. Using these criteria, five patients required surgical intervention for typhlitis or its sequelae and one for acute appendicitis. There was one perioperative death resulting from miliary tuberculosis. Among the 21 patients managed medically, there was 1 death resulting from typhlitis in a patient in whom surgery was deferred because of her multiple failures to enter remission.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19860201)57:3&lt;603::AID-CNCR2820570335&gt;3.0.CO;2-K</identifier><identifier>PMID: 3484659</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Antineoplastic Agents - adverse effects ; Biological and medical sciences ; Child ; Child, Preschool ; Enterocolitis - etiology ; Enterocolitis - surgery ; Enterocolitis - therapy ; Female ; Fever - etiology ; Gastrointestinal Hemorrhage - complications ; Hematologic and hematopoietic diseases ; Humans ; Infant ; Leukemia, Myeloid, Acute - complications ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Neutropenia - complications</subject><ispartof>Cancer, 1986-02, Vol.57 (3), p.603-609</ispartof><rights>Copyright © 1986 American Cancer Society</rights><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4955-4e82ff61597e6b2d356726d623c5924a09eada952ad3c89555d3b4ce563be4c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8583466$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3484659$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shamberger, Robert C.</creatorcontrib><creatorcontrib>Weinstein, Howard J.</creatorcontrib><creatorcontrib>Delorey, Marcia J.</creatorcontrib><creatorcontrib>Levey, Raphael H.</creatorcontrib><title>The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia</title><title>Cancer</title><addtitle>Cancer</addtitle><description>The treatment of acute leukemia in childhood has been increasingly successful. Infectious complications are the major cause of morbidity and mortality among these patients receiving aggressive chemotherapy. In particular, neutropenic enterocolitis or typhlitis has had a reported mortality of 50% to 100%. The authors reviewed a series of 77 previously untreated patients with acute myelogenous leukemia begun on treatment from March 1976 to June of 1984 to better define the characteristics of typhlitis and its optimum management. Twenty‐five patients had episodes of typhlitis, characterized by fever, abdominal pain, and tenderness, occurring during periods of neutropenia. Ten of these patients had watery diarrhea as a major additional symptom, and nine patients had a significant episode of gastrointestinal bleeding. In seven instances, blood culture results were positive, all for intestinal flora. The episodes of typhlitis occurred most frequently during the induction therapy (19 patients). Five patients experienced typhlitis during maintenance therapy, and one patient had acute appendicitis. Two patients had typhlitis during their reinduction therapy, and of note, one had had abdominal symptoms during her initial induction. All patients were treated initially with broad‐spectrum antibiotics and bowel rest. Four criteria have been used for surgical intervention: (1) persistent gastrointestinal bleeding after resolution of neutropenia and thrombocytopenia and correction of clotting abnormalities; (2) evidence of free intraperitoneal perforation; (3) clinical deterioration requiring support with vasopressors, or large volumes of fluid, suggesting uncontrolled sepsis; and (4) development of symptoms of an intra‐abdominal process, in the absence of neutropenia, which would normally require surgery. Using these criteria, five patients required surgical intervention for typhlitis or its sequelae and one for acute appendicitis. There was one perioperative death resulting from miliary tuberculosis. Among the 21 patients managed medically, there was 1 death resulting from typhlitis in a patient in whom surgery was deferred because of her multiple failures to enter remission.</description><subject>Adolescent</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Enterocolitis - etiology</subject><subject>Enterocolitis - surgery</subject><subject>Enterocolitis - therapy</subject><subject>Female</subject><subject>Fever - etiology</subject><subject>Gastrointestinal Hemorrhage - complications</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Leukemia, Myeloid, Acute - complications</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neutropenia - complications</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVUVtr1EAYHUSpa-tPEOZBpH3IOplbklWEGm-lxQWpIL4Ms5Mvm7GTyZpJKPn3znbXBftQ8Onj41w4nIPQ-5TMU0Lo65QUWUJSTk_TIpeEkvRMZAv2VhK2WJxffEjKr-U3mlMiMsKYeMfmZF4u39Dk8hGaHcSP0YwQkieCsx9P0bMQfsU3o4IdoSPGcy5FMUPtdQO4hcoa7bD2FQ5jv757Wu31GlrwA-5qPEybxtnBBmw9No11VQ8e39qhwdqMA2DfeTe1m6Yz02ANPm0ncN0afDeGM-xgvIHW6hP0pNYuwPP9PUbfP328Lr8kV8vPF-X5VWJ4IUTCIad1LVNRZCBXtGJCZlRWkjIjCso1KUBXuhBUV8zkUSEqtuIGhGQr4IayY_Rq57vpu98jhEG1NhhwTnuIgVQmZS54wSLx545o-i6EHmq16W2r-0mlRG23UNs61bZO9XcLJTLFVNxCqbiF-neLiBBVLhVVl9H8xT7FuIoVH6z35Uf85R7XITZe99obGw60XOSMSxlpsKPdWgfTfwV8MN89hP0BPKW0kw</recordid><startdate>19860201</startdate><enddate>19860201</enddate><creator>Shamberger, Robert C.</creator><creator>Weinstein, Howard J.</creator><creator>Delorey, Marcia J.</creator><creator>Levey, Raphael H.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19860201</creationdate><title>The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia</title><author>Shamberger, Robert C. ; Weinstein, Howard J. ; Delorey, Marcia J. ; Levey, Raphael H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4955-4e82ff61597e6b2d356726d623c5924a09eada952ad3c89555d3b4ce563be4c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adolescent</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Enterocolitis - etiology</topic><topic>Enterocolitis - surgery</topic><topic>Enterocolitis - therapy</topic><topic>Female</topic><topic>Fever - etiology</topic><topic>Gastrointestinal Hemorrhage - complications</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Leukemia, Myeloid, Acute - complications</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neutropenia - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shamberger, Robert C.</creatorcontrib><creatorcontrib>Weinstein, Howard J.</creatorcontrib><creatorcontrib>Delorey, Marcia J.</creatorcontrib><creatorcontrib>Levey, Raphael H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shamberger, Robert C.</au><au>Weinstein, Howard J.</au><au>Delorey, Marcia J.</au><au>Levey, Raphael H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1986-02-01</date><risdate>1986</risdate><volume>57</volume><issue>3</issue><spage>603</spage><epage>609</epage><pages>603-609</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>The treatment of acute leukemia in childhood has been increasingly successful. Infectious complications are the major cause of morbidity and mortality among these patients receiving aggressive chemotherapy. In particular, neutropenic enterocolitis or typhlitis has had a reported mortality of 50% to 100%. The authors reviewed a series of 77 previously untreated patients with acute myelogenous leukemia begun on treatment from March 1976 to June of 1984 to better define the characteristics of typhlitis and its optimum management. Twenty‐five patients had episodes of typhlitis, characterized by fever, abdominal pain, and tenderness, occurring during periods of neutropenia. Ten of these patients had watery diarrhea as a major additional symptom, and nine patients had a significant episode of gastrointestinal bleeding. In seven instances, blood culture results were positive, all for intestinal flora. The episodes of typhlitis occurred most frequently during the induction therapy (19 patients). Five patients experienced typhlitis during maintenance therapy, and one patient had acute appendicitis. Two patients had typhlitis during their reinduction therapy, and of note, one had had abdominal symptoms during her initial induction. All patients were treated initially with broad‐spectrum antibiotics and bowel rest. Four criteria have been used for surgical intervention: (1) persistent gastrointestinal bleeding after resolution of neutropenia and thrombocytopenia and correction of clotting abnormalities; (2) evidence of free intraperitoneal perforation; (3) clinical deterioration requiring support with vasopressors, or large volumes of fluid, suggesting uncontrolled sepsis; and (4) development of symptoms of an intra‐abdominal process, in the absence of neutropenia, which would normally require surgery. Using these criteria, five patients required surgical intervention for typhlitis or its sequelae and one for acute appendicitis. There was one perioperative death resulting from miliary tuberculosis. Among the 21 patients managed medically, there was 1 death resulting from typhlitis in a patient in whom surgery was deferred because of her multiple failures to enter remission.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>3484659</pmid><doi>10.1002/1097-0142(19860201)57:3&lt;603::AID-CNCR2820570335&gt;3.0.CO;2-K</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1986-02, Vol.57 (3), p.603-609
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_76685493
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Antineoplastic Agents - adverse effects
Biological and medical sciences
Child
Child, Preschool
Enterocolitis - etiology
Enterocolitis - surgery
Enterocolitis - therapy
Female
Fever - etiology
Gastrointestinal Hemorrhage - complications
Hematologic and hematopoietic diseases
Humans
Infant
Leukemia, Myeloid, Acute - complications
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical sciences
Neutropenia - complications
title The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A38%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20medical%20and%20surgical%20management%20of%20typhlitis%20in%20children%20with%20acute%20nonlymphocytic%20(myelogenous)%20leukemia&rft.jtitle=Cancer&rft.au=Shamberger,%20Robert%20C.&rft.date=1986-02-01&rft.volume=57&rft.issue=3&rft.spage=603&rft.epage=609&rft.pages=603-609&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/1097-0142(19860201)57:3%3C603::AID-CNCR2820570335%3E3.0.CO;2-K&rft_dat=%3Cproquest_cross%3E76685493%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76685493&rft_id=info:pmid/3484659&rfr_iscdi=true